FTO-Dependent N (6)-Methyladenosine Modifications Inhibit Ovarian Cancer Stem Cell Self-Renewal by Blocking cAMP Signaling. Huang, H. et al. (47). The gene discussed is FTO; the disease is ovarian carcinoma.